跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANDESARTAN/HCT SANDOZ 32mg/25mg candesartan cilexetil/hydrochlorothiazide 32mg/25mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
CANDESARTAN/HCT SANDOZ 32mg/25mg candesartan cilexetil/hydrochlorothiazide 32mg/25mg tablet blister pack
Approved
STANDARD
CANDESARTAN/HCT SANDOZ 32mg/25mg candesartan cilexetil/hydrochlorothiazide 32mg/25mg tablet blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
331ecb73c82c65fa
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
331ecb73c82c65fa
Product Name
CANDESARTAN/HCT SANDOZ 32mg/25mg candesartan cilexetil/hydrochlorothiazide 32mg/25mg tablet blister pack
Artg Id
195278
Artg Name
CANDESARTAN/HCT SANDOZ 32mg/25mg candesartan cilexetil/hydrochlorothiazide 32mg/25mg tablet blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2013-03-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/79609e76a80f97b1c89ed8eb303898cb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/66e86f67be8a239d7b5cee8666682691.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
331ecb73c82c65fa
Type
Standard
Back to TGA Approvals